Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

Specimen Handling 624pembrolizumab 603Magnetic Resonance Spectroscopy 550Carboplatin 444Cisplatin 394Cyclophosphamide 392Biopsy 368Paclitaxel 320Nivolumab 320Gemcitabine 313Radiotherapy 279Bevacizumab 242Dexamethasone 220fludarabine 210Docetaxel 197durvalumab 192Oxaliplatin 184venetoclax 182atezolizumab 182Fluorouracil 174Rituximab 172Pemetrexed 171Capecitabine 167Doxorubicin 164Radiation 162Radiosurgery 156Ipilimumab 143Etoposide 142Leucovorin 140Lenalidomide 136

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Coal Tar × 90 days × Clear all
NCT07538050 2026-05-28

SCALE AIM 2

The Cleveland Clinic

Phase NA Recruiting
1,000 enrolled
Gynecologic

Cervical Cancer Screening

NCT05012813 2026-03-09

Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer

OHSU Knight Cancer Institute

Phase NA Completed
28 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡